• Inonotus hispidus Polypeptide Suppresses Inflammatory Bone L

  2026-08-05

  This study demonstrates that a purified polypeptide from Inonotus hispidus (IHP) alleviates periodontitis by targeting inflammatory bone loss mechanisms. Through antimicrobial, anti-inflammatory, and signaling pathway regulation, IHP offers a novel approach to managing this chronic oral disease with translational potential for advanced immunodetection workflows.

• Solving Organoid and EMT Assay Challenges with A 83-01 (ALK

  2026-08-04

  This article delivers scenario-driven, evidence-backed guidance for biomedical researchers and lab technicians exploring the use of A 83-01 (ALK inhibitor), SKU A3133. Drawing on recent advances in organoid systems and EMT research, we address real-world assay challenges and demonstrate how this selective ALK-5 inhibitor from APExBIO enables reproducible, high-fidelity TGF-β signaling modulation.

• Structural Insights into ASCH Domains and N4-Acetylcytidine

  2026-08-04

  Meng et al. (2025) present the first high-resolution structural analysis of ASCH domain-containing proteins, revealing the substrate specificity and catalytic mechanism of the E. coli enzyme EcYqfB in converting free N4-acetylcytidine to cytidine. These findings refine our understanding of nucleotide processing enzymes and provide a framework for advanced RNA epigenetics research.

• O-GlcNAcylation Rewires Glycolysis in Wnt-Induced Osteogenes

  2026-08-03

  The reference study reveals that O-GlcNAcylation is crucial for Wnt3a-driven bone formation by modulating aerobic glycolysis, specifically through post-translational modification of PDK1. These findings provide new mechanistic insights into how Wnt signaling controls osteoblast differentiation and bone anabolism, with practical implications for osteoporosis research and targeted pathway modulation.

• GW 4869 Hydrochloride Hydrate: Redefining Exosome Inhibition

  2026-08-03

  Discover how GW 4869 hydrochloride hydrate enables precise, mechanism-driven inhibition of exosome biogenesis in lupus nephritis models. This article provides advanced assay insights and practical protocols, setting it apart as an essential resource for researchers investigating vesicle-mediated kidney injury.

• Sphingosine-1-phosphate: Applied Workflows in Cell Survival

  2026-08-02

  Sphingosine-1-phosphate (S1P) enables researchers to precisely dissect cell proliferation, vascular maturation, and apoptosis inhibition mechanisms in both vascular and neuronal models. This guide delivers actionable protocol enhancements, troubleshooting advice, and translational insights, anchored by the latest reference breakthroughs and APExBIO’s rigorously validated S1P reagent.

• Autophagy Modulates Resveratrol-Induced Apoptosis in RCC Cel

  2026-08-01

  This study demonstrates that autophagy acts as a protective mechanism against resveratrol-induced apoptosis in renal cell carcinoma 786-O cells. By dissecting the interplay between mitochondrial damage, caspase-3 activation, ROS generation, and autophagy, the research highlights promising combinatorial strategies for enhancing therapeutic efficacy in apoptosis research.

• Acridine Orange hydrochloride: Practical Guide for DNA/RNA S

  2026-07-31

  Acridine Orange hydrochloride offers reliable, differential staining of DNA and RNA for cell cycle analysis, apoptosis detection, and flow cytofluorometric assays. It should be used in workflows requiring precise nucleic acid discrimination, but is not suitable for protocols requiring long-term dye solution storage or applications outside nucleic acid staining.

• Nanomedicine Restores Stromal Balance, Inhibits Pancreatic T

  2026-07-31

  Fu et al. present a multistage, acid-responsive nanomedicine targeting pancreatic ductal adenocarcinoma stroma, enabling sequential release of stroma-modulating agents and gemcitabine. This strategy demonstrates robust tumor regression in vivo, suggesting a promising avenue for overcoming chemoresistance in dense tumor microenvironments.

• KR-12 (human) TFA: Mechanistic Insights and Translational Pr

  2026-07-30

  Explore the multifaceted bioactivity of KR-12 human antimicrobial peptide, including its mechanistic underpinnings and translational potential. This article provides fresh comparative analysis, protocol guidance, and evidence-based perspectives for advanced antimicrobial research.

• Practical Guide: Mouse Tissue Lysis Kit (K1038) for Direct G

  2026-07-30

  The Mouse Tissue Lysis Kit (K1038) enables rapid and efficient lysis of mouse tissues for direct use in PCR-based genotyping assays, eliminating the need for traditional DNA extraction and purification. This kit is intended for research applications in molecular biology and should not be used for diagnostic or medical purposes.

• GW 4869 Hydrochloride Hydrate: Optimizing Exosome Inhibition

  2026-07-29

  GW 4869 hydrochloride hydrate empowers researchers to precisely modulate exosome release, enabling reliable dissection of intercellular signaling in disease and regenerative models. This article breaks down validated workflows, troubleshooting insights, and the transformative impact of this APExBIO inhibitor in cutting-edge experimental contexts.

• ECL Chemiluminescent Substrate Detection Kit: Ultra-Sensitiv

  2026-07-29

  Unlock the next level of immunoblotting with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), designed for picogram-scale protein detection and extended signal stability. This guide bridges advanced protocols, troubleshooting, and real-world research applications for scientists seeking reliable, high-sensitivity western blot chemiluminescent detection.

• KCNE4 Modulates Psora 4 Blockade of Kv1.3 in Immune Cells

  2026-07-28

  This study demonstrates that the auxiliary subunit KCNE4 alters the pharmacological properties of the Kv1.3 potassium channel, specifically modifying how intracellular blockers like Psora 4 inhibit the channel. The findings highlight the complexity of Kv1.3 modulation in immune cells and underscore the importance of channel composition in designing selective immunomodulatory strategies.

• Selective β1 Blockade Preserves Hematopoietic Recovery Post-

  2026-07-28

  The referenced study demonstrates that nonselective β-adrenergic blockers impair hematopoietic regeneration after hematopoietic cell transplantation (HCT), while selective β1-adrenergic blocking agents do not. These findings highlight the importance of receptor selectivity in post-transplant pharmacotherapy and suggest that β1-selective inhibition, such as with Metoprolol Tartrate, preserves hematopoietic recovery.

8078 records 3/539 page Previous Next 12345 下5页 Last page